Precision BioSciences, Inc. (DTIL) Social Stream
PRECISION BIOSCIENCES INC (DTIL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PRECISION BIOSCIENCES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-21 | 5 | $26 | $13 | $20 | $0.758 | 2538.52% |
| 2021-11-10 | 5 | $24 | $13 | $19.5 | $0.758 | 2472.56% |
| 2021-11-11 | 5 | $24 | $13 | $18.75 | $0.758 | 2373.61% |
| 2021-12-13 | 4 | $24 | $11 | $18.25 | $0.758 | 2307.65% |
| 2022-03-16 | 5 | $24 | $11 | $18.25 | $0.758 | 2307.65% |
| 2022-03-22 | 5 | $20 | $11 | $16.25 | $0.758 | 2043.8% |
| 2022-05-09 | 4 | $20 | $16 | $18 | $0.758 | 2274.67% |
| 2022-05-23 | 4 | $20 | $16 | $17.666 | $0.758 | 2230.61% |
| 2022-06-09 | 4 | $20 | $16 | $17.666 | $0.758 | 2230.61% |
| 2022-06-17 | 5 | $20 | $7 | $15 | $0.758 | 1878.89% |
| 2022-06-23 | 6 | $20 | $7 | $13.75 | $0.758 | 1713.98% |
| 2022-08-16 | 5 | $20 | $2 | $10 | $0.758 | 1219.26% |
| 2023-03-10 | 5 | $17 | $1 | $7.4 | $0.758 | 876.25% |
| 2023-03-15 | 5 | $17 | $1 | $6.8 | $0.758 | 797.1% |
The Trend in the Analyst Price Target
DTIL's average price target has moved down $11.23 over the prior 19 months.
DTIL reports an average of 770.27% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-09 | 4 | 20 | 16 | 17.666 | 1.450 | 1118.34% |
| 2022-06-09 | 5 | 20 | 16 | 17.666 | 1.450 | 1118.34% |
| 2022-06-17 | 5 | 20 | 7 | 15.000 | 1.260 | 1090.48% |
| 2023-03-10 | 5 | 17 | 1 | 7.400 | 0.910 | 713.19% |
| 2023-03-15 | 5 | 17 | 1 | 6.800 | 0.899 | 656.4% |
DTIL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 3 | 0 | 2 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 36 months, DTIL's average broker recommendation rating worsened by 0.67.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for DTIL as an investment opportunity.
- In terms of how PRECISION BIOSCIENCES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1662.56% of that group.
- In terms of how PRECISION BIOSCIENCES INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1131.19% of that group.
- DTIL has a higher average analyst price target than 452.59% of Healthcare stocks.
- PRECISION BIOSCIENCES INC's number of analysts covering the stock is greater than 511.12% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PRECISION BIOSCIENCES INC are GNFT, INMB, and GMDA.
View All Top Stocks by Price Target
Is DTIL a Buy, Hold or Sell? See the POWR Ratings now!